BethMBeadleMDPhD

Radiation Oncology • Stanford, CA

Head & Neck

Professor of Radiation Oncology

Join to view full profile

Dr. Beadle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Beadle's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Summary

Dr. Beth Beadle is a radiation oncologist in Palo Alto, CA and is affiliated with Stanford Health Care. She received her medical degree from Northwestern University Feinberg School of Medicine and has been in practice 13 years. She specializes in head & neck and ocular radiation oncology.

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2005 - 2009
McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 2004 - 2005
Northwestern University The Feinberg School of MedicineClass of 2004

Certifications & Licensure

CA State Medical License 2016 - 2025
TX State Medical License 2009 - 2020
American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

42 citations
Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
Ryan P. Goepfert, Jan S. Lewin, Martha P. Barrow, G. Brandon Gunn, C. David Fuller
International Journal of Radiation Oncology, Biology, Physics. 2017-03-15
57 citations
Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison
Abdallah S.R. Mohamed, Brian P. Hobbs, Katherine A. Hutcheson, Michael S. Murri, Naveen Garg
Radiotherapy and Oncology. 2017-08-01
35 citations
Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Ryan P. Goepfert, Jan S. Lewin, Martha P. Barrow, C. David Fuller, Stephen Y. Lai
The Laryngoscope. 2017-04-01

Journal Articles

The Impact of HPV Testing for Oropharyngeal Cancers: Why the Addendum Matters
Beth Beadle, MD, Cancer Cytopathology

Press Mentions

Study Identifies Cancer Features That Could Guide Personalized RadiotherapyNovember 3rd, 2021
OK to Skip Postop RT to Pathologically Node-Negative NeckJuly 1st, 2019
The Bay Area's Top Doctors of 2019January 17th, 2019
Join now to see all